All In Biotech

Drug Trial Radar · NCT04033445

A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

CNTO1959UCO3001: A Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,064 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

1,064

Actual

Start

Sep 26, 2019

Primary completion

Sep 19, 2023

Study completion Jul 16, 2027

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Jul 26, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis (UC).

Conditions

  • Ulcerative Colitis

Interventions

  • PlaceboDrug

    Participants will receive matching placebo IV or SC.

  • GuselkumabDrug

    Participants will receive guselkumab IV or SC.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Induction Study 1: Percentage of Participants With Clinical Response at Week I-12Time frame: At Week I-12
  2. Induction Study 2: Percentage of Participants With Clinical Remission at Week I-12Time frame: At Week I-12
  3. Maintenance Study: Percentage of Participants With Clinical Remission at Week M-44Time frame: At Week M-44

Locations

392 sites in 34 countries. Site status is shown where the registry gives one.

  • Om Research LLC

    Lancaster, California

  • UCLA

    Los Angeles, California

  • Peak Gastroenterology Associates 1

    Colorado Springs, Colorado

  • Florida Research Network, LLC

    Gainesville, Florida

  • University of Florida Health Jacksonville

    Gainesville, Florida

  • Harmony Medical Research Institute, Inc.

    Hialeah, Florida

  • UF Health Jacksonville Gastroenterology Emerson

    Jacksonville, Florida

  • I.H.S. Health. LLC

    Kissimmee, Florida

  • Columbus Clinical Services LLC

    Miami, Florida

  • Vista Health Research, LLC

    Miami, Florida

  • Orlando Health

    Orlando, Florida

  • Care Access Research, Orlando

    Orlando, Florida

  • Synexus Clinical Research US Inc 2

    Pinellas Park, Florida

  • Univ. of South Florida Med. Group

    Tampa, Florida

  • Atlanta Gastroenterology Associates

    Atlanta, Georgia

  • Morehouse School of Medicine

    Atlanta, Georgia

  • The Emory Clinic

    Atlanta, Georgia

  • Atlanta Gastroenterology Associates 1

    Atlanta, Georgia

  • Atlanta Center For Gastroenterology

    Decatur, Georgia

  • Gastroenterolgy Associates of Central GA

    Macon, Georgia

  • University of Chicago

    Chicago, Illinois

  • Health Science Research Center

    Pratt, Kansas

  • Tri-State Gastroenterology Assoc

    Crestview Hills, Kentucky

  • Baystate Medical Center

    Springfield, Massachusetts

  • Clinical Research Institute of Michigan, LLC

    Clinton Township, Michigan

  • Revive Research Institute

    Farmington Hills, Michigan

  • Infusion Associates

    Grand Rapids, Michigan

  • Mid-America Gastro-Intestinal Consultants

    Kansas City, Missouri

  • Barnes-jewish Hospital

    St Louis, Missouri

  • Las Vegas Medical Research

    Las Vegas, Nevada

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Duke University Hospital Medical Center

    Raleigh, North Carolina

  • Synexus Clinical Research US Inc

    Columbus, Ohio

  • Digestive Specialists, Inc

    Springboro, Ohio

  • Gastro Intestinal Research Institute of Northern Ohio LLC

    Westlake, Ohio

  • Care Access Research, Poland

    Youngstown, Ohio

  • Digestive Disease Specialists Inc

    Oklahoma City, Oklahoma

  • US Digestive Health

    Wyomissing, Pennsylvania

  • Synexus Clinical Research US Inc 1

    Anderson, South Carolina

  • Gastroenterology Associates of Orangeburg, SC

    Orangeburg, South Carolina

Showing 40 of 392 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.